References
- Karevan G, Ahmadi K, Taheri RA, Fasihi-Ramandi M. Immunogenicity of glycine nanoparticles containing a chimeric antigen as brucella vaccine candidate. Clin Exp Vaccine Res 2021;10:35-43. https://doi.org/10.7774/cevr.2021.10.1.35
- Maleki M, Salouti M, Shafiee Ardestani M, Talebzadeh A. Preparation of a nanovaccine against brucella melitensis M16 based on PLGA nanoparticles and oligopolysaccharide antigen. Artif Cells Nanomed Biotechnol 2019;47:4248-56. https://doi.org/10.1080/21691401.2019.1687490
- Sadeghi Z, Fasihi-Ramandi M, Azizi M, Bouzari S. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against brucella melitensis and brucella abortus infection. J Biotechnol 2020;310:89-96. https://doi.org/10.1016/j.jbiotec.2020.01.016
- Abkar M, Lotfi AS, Amani J, et al. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization. Vet Res Commun 2015;39:217-28. https://doi.org/10.1007/s11259-015-9645-2
- Shim S, Soh SH,Im YB, et al. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19. Int J Med Microbiol 2020;310:151362.
- Abkar M, Fasihi-Ramandi M, Kooshki H, Sahebghadam LotfiA. Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against brucella melitensis infection. Int J Nanomedicine 2017;12:8769-78. https://doi.org/10.2147/IJN.S149774
- Razei A,Cheraghali AM, Saadati M, et al. Gentamicin-loaded chitosan nanoparticles improve its therapeutic effects on brucella-infected J774A.1 murine cells. Galen Med J 2019;8:e1296.
- Abkar M, Fasihi-Ramandi M, Kooshki H, Lotfi AS. Intraperitoneal immunization with urease loaded N-trimethyl chitosan nanoparticles elicits high protection against brucella melitensis and brucella abortus infections. Immunol Lett 2018;199:53-60. https://doi.org/10.1016/j.imlet.2018.03.004
- Abdollahi A, Mansouri S, Amani J, Fasihi-Ramandi M, Moradi M. Immunoreactivity evaluation of a new recombinant chimeric protein against brucella in the murine model. Iran J Microbiol 2016;8:193-202.
- Kaushik P, Singh DK, Kumar SV, et al. Protection of mice against brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides. Vet Res Commun 2010;34:119-32. https://doi.org/10.1007/s11259-009-9337-x
- Huy TX, Nguyen TT, Reyes AW, et al. Immunization with a combination of four recombinant brucella abortus proteins Omp16, Omp19, Omp28, and L7/L12 induces T helper 1 immune response against virulent B. abortus 544 infection in BALB/c mice. Front Vet Sci 2021;7:577026.
- Ghasemi A, Salari MH, Zarnani AH, et al.Immune reactivity of brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins. Iran J Microbiol 2013;5:19-23.
- Yao L, Wu CX, Zheng K, et al. Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of brucella melitensis in mice. Res Vet Sci 2015;100:61-7. https://doi.org/10.1016/j.rvsc.2015.03.030
- Onate AA, Cespedes S, Cabrera A, et al. A DNA vaccine encoding Cu,Zn superoxide dismutase of brucella abortus induces protective immunity in BALB/c mice. Infect Immun 2003;71:4857-61. https://doi.org/10.1128/IAI.71.9.4857-4861.2003
- Estein SM, Cheves PC, Fiorentino MA,Cassataro J, Paolicchi FA, Bowden RA. Immunogenicity of recombinant Omp31 from brucella melitensis in rams and serum bactericidal activity against B. ovis. Vet Microbiol 2004;102:203-13. https://doi.org/10.1016/j.vetmic.2004.05.004
- Cassataro J, Velikovsky CA,Bruno L, et al.Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol 2007;14:869-74. https://doi.org/10.1128/CVI.00472-06
- Cassataro J, Pasquevich KA, Estein SM, et al. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination. Vaccine 2007;25:4437-46. https://doi.org/10.1016/j.vaccine.2007.03.028
- Clausse M, Diaz AG, Ghersi G, et al. The vaccine candidate BLSOmp31 protects mice against brucella canis infection. Vaccine 2013;31:6129-35. https://doi.org/10.1016/j.vaccine.2013.07.041
- Masjedian Jezi F, Razavi S, Mirnejad R, Zamani K. Immunogenic and protective antigens of brucella as vaccine candidates. Comp Immunol Microbiol Infect Dis 2019;65:29-36. https://doi.org/10.1016/j.cimid.2019.03.015
- Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, ZarnaniAH. Simultaneous immunization of mice with Omp31 and TF provides protection against brucella melitensis infection. Vaccine 2015;33:5532-8. https://doi.org/10.1016/j.vaccine.2015.09.013
- Yang X, Walters N, Robison A, Trunkle T, Pascual DW. Nasal immunization with recombinant brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine 2007;25:2261-8. https://doi.org/10.1016/j.vaccine.2006.12.004
- Abkar M, Alamian S, Sattarahmady N. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of brucella melitensis Omp31. Immunol Lett 2019;207:28-35. https://doi.org/10.1016/j.imlet.2019.01.010
- Rana T. Nano-selenium on reproduction and immunocompetence: an emerging progress and prospect in the productivity of poultry research. Trop Anim Health Prod 2021;53:324.
- Molanouri Shamsi M, Chekachak S, Soudi S, et al. Effects of exercise training and supplementation with selenium nanoparticle on T-helper 1 and 2 and cytokine levels in tumor tissue of mice bearing the 4 T1 mammary carcinoma. Nutrition 2019;57:141-7. https://doi.org/10.1016/j.nut.2018.05.022
- Raahati Z, Bakhshi B, Najar-Peerayeh S. Selenium nanoparticles induce potent protective immune responses against vibrio cholerae WC vaccine in a mouse model. J Immunol Res 2020;2020:8874288.
- Mahdavi M, Mavandadnejad F, Yazdi MH, et al. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. JInfect Public Health 2017;10:102-9. https://doi.org/10.1016/j.jiph.2016.02.006
- Glenny AT. The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol 1926;29:38-40.
- Gogoi H, Mani R, Malik A, Sehrawat P, Bhatnagar R. Coadministration of aluminium hydroxide nanoparticles and protective antigen domain 4 encapsulated non-ionic surfactant vesicles show enhanced immune response and superior protection against anthrax. Vaccines (Basel) 2020;8:571.
- Amini Y, Moradi B, Fasihi-Ramandi M.Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis. Artif Cells Nanomed Biotechnol 2017;45:1331-5. https://doi.org/10.1080/21691401.2016.1233111
- Amani J, Ghasemi A, Ranjbar R, Shabani M, Zandemami M, Golmohammadi R. Immune reactivity of sera obtained from brucellosis patients and vaccinated-rabbits to a fusion protein from brucella melitensis. Iran J Basic Med Sci 2015;18:350-5.
- GhasemiA, Ranjbar R,AmaniJ.In silico analysis of chimeric TF, Omp31 and BP26 fragments of brucella melitensis for development of a multi subunit vaccine candidate. Iran J Basic Med Sci 2014;17:172-80.
- Ghasemi A, Salari MH, Zarnani AH, et al. Immunogenicity assessment of brucella mellitensis HSP and TF proteins by immunized rabbit serum.Iran J Allergy Asthma Immunol 2013;12:192-4.
- He P, Zou Y, Hu Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum Vaccin Immunother 2015;11:477-88. https://doi.org/10.1080/21645515.2014.1004026
- Morcol T, Hurst BL, Tarbet EB. Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice. Vaccine 2017;35(35 Pt B):4569-77. https://doi.org/10.1016/j.vaccine.2017.07.016
- Morcol T, Nagappan P, Bell SJ, Cawthon AG. Influenza A(H5N1) virus subunit vaccine administered with CaPNP adjuvant induce high virus neutralization antibody titers in mice. AAPS PharmSciTech 2019;20:315.
- Pagheh AS, Sarvi S, Gholami S, et al. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice. Microb Pathog 2019;134:103601.
- Yousefi S, Abbassi-Daloii T, Tahmoorespur M, Sekhavati MH. Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis? Iran J Basic Med Sci 2019;22:360-6.
- Shojaei M, Tahmoorespur M, Soltani M, Sekhavati MH. Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB/c mice. Iran J Basic Med Sci 2018;21:957-64.
- Sokolovska A, Hem SL, HogenEsch H. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine 2007;25:4575-85. https://doi.org/10.1016/j.vaccine.2007.03.045
- Dodangeh S, Fasihi-Ramandi M, Daryani A, et al. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice. Microb Pathog 2021;153:104764.